As of November 6, 2026, GoodRx Holdings, Inc. is a publicly traded company (Nasdaq: GDRX). The largest holder reporting an active stake on Schedule 13D is Francisco Partners IV, L.P., at 32.9%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, August 26, 2026).
Is this your company?
About to sign with, pay or invest in GoodRx Holdings, Inc.? See the free Snapshot first.
Free to see. No signup.
Is GoodRx Holdings, Inc. a real, registered company?
- GoodRx Holdings, Inc. files with the SEC under CIK 1809519 (its SEC filings).
- Its shares are listed under the ticker GDRX on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Santa Monica, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under GoodRx Holdings, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Thomas Chan, Chief Accounting Officer (Form 8-K filed 2026-04-24). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Francisco Partners IV, L.P. (filed 2026-08-26).
Who are GoodRx Holdings, Inc.'s owners and officers?
GoodRx Holdings, Inc.: incorporated in Delaware; business address in Santa Monica, California; industry Services-Computer Processing & Data Preparation (Schedule 13D/A, 2026-08-26).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-08-26 | Francisco Partners Iv, L.P. | 32.9% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-10-30 | The Vanguard Group | 9.33% |
| Schedule 13D/A, 2025-10-16 | Spectrum Equity Vii, L.P. | 0% |
| Schedule 13D/A, 2025-09-08 | Spectrum Equity Vii, L.P. | 8.28% |
| Schedule 13D/A, 2025-07-03 | Spectrum Equity Vii, L.P. | 12.9% |
Questions about who owns GoodRx Holdings, Inc.
Who owns GoodRx Holdings, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of GoodRx Holdings, Inc.: Francisco Partners Iv, L.P. (32.9%, Schedule 13D/A, filed 2026-08-26).
When did Francisco Partners Iv, L.P. buy into GoodRx Holdings, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Francisco Partners Iv, L.P. on this page is the Schedule 13D/A, filed 2026-08-26, reporting 32.9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on GoodRx Holdings, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on GoodRx Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on GoodRx Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-24 | Thomas Chan | Chief Accounting Officer | appointed | |
| Form 8-K, 2026-04-03 | Ian T. Clark | departed | 2026-03-31 |
Which insiders own GoodRx Holdings, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 5,644,226 shares, 378,785 held directly and 5,265,441 indirectly (Form 4, 2026-11-03).
- , a director: 5,606,898 shares, 341,457 held directly and 5,265,441 indirectly (Form 4, 2026-10-26).
- , a director: 898,490 shares (Form 4, 2026-10-15).
- , a director: 472,997 shares, 290,097 held directly and 182,900 indirectly (Form 4, 2026-06-17).
- , a director: 426,286 shares (Form 4, 2026-06-17).
Shares only: the company's cover page does not give one share count for a single class, so no percentage is worked out.
How much has GoodRx Holdings, Inc. raised?
No fundraising or offering filing from GoodRx Holdings, Inc. is on file with us.
Keep reading
More on GoodRx Holdings, Inc. and the records around it.
GoodRx Holdings, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes Apr 2026
Companies that share a holder
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/goodrx